AMZN
Amazon.com, Inc.
AMZN has the edge over GIL overall, supported by stronger valuation and stronger modeled upside.
GIL
Gildan Activewear Inc.
GIL offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
GIL Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Healthy | |
| Weak |
GIL's revenue, profitability and cash flow are currently healthy, but its balance sheet is weak.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over GIL in the historical PE scenario, which offers more potential upside but is not a forecast.
GIL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 9.2x | $34.83 | — |
| Cheap | 11x | $5.67 | -84% |
| Fair | 17x | $9.22 | -74% |
| Expensive | 24x | $12.73 | -63% |
| Current | 65x | $34.83 | — |
Historical ranges are pointers, not guarantees.
GIL's PE is in its expensive range at 65x. On analysts' estimates for next year's earnings, today's price would be 9.2x, in its cheap range.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
GIL Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Decline | |
| Stable | |
| Stable | |
| Limited | |
| Moderate |
Analysts expect GIL's earnings to decline, with its revenue and profitability holding steady.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the stronger earnings trend. Trailing diluted EPS is up 75% for AMZN versus GIL down 79%.
GIL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.78 | +599% |
| Q3 2025 | $3.13 | +24% |
| Q3 2024 | $2.52 | -3.8% |
| Q2 2024 | $2.43 | -11% |
| Q1 2024 | $2.96 | +10% |
| Q4 2023 | $3.04 | +4.1% |
| Q3 2023 | $2.62 | -22% |
| Q2 2023 | $2.73 | -21% |
| Q1 2023 | $2.69 | -20% |
GIL's earnings per share have fallen from their peak: $0.54 over the past year, against $3.45 in mid-2022.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over GIL on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN's operating margin was 14% last quarter, up 4.2 points from the same quarter a year ago, near the top of its range since 2019.
GIL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1.5B | +68% |
| Q1 2026 | $1.2B | +64% |
| Q4 2025 | $1.1B | +33% |
| Q3 2025 | $910.6M | +2.2% |
| Q2 2025 | $918.5M | +6.5% |
| Q1 2025 | $711.7M | +2.3% |
| Q4 2024 | $821.5M | +5% |
| Q3 2024 | $891.1M | +2.4% |
GIL's revenue has grown year over year for nine quarters in a row: $1.5B last quarter, up 68% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 17% | -4.9 points |
| Q1 2026 | 5.1% | -13 points |
| Q4 2025 | 17% | -4.6 points |
| Q3 2025 | 21% | N/A |
| Q2 2025 | 22% | +0.1 points |
| Q1 2025 | 18% | +2.2 points |
| Q4 2024 | 22% | +6.7 points |
| Q3 2024 | 22% | +3.8 points |
GIL has the edge over AMZN on profitability, with a higher operating margin.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
GIL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $316.5M | +93% |
| Q1 2026 | -$309.9M | -$145.4M |
| Q4 2025 | $280.6M | +65% |
| Q3 2025 | $203.1M | +35% |
| Q2 2025 | $163.7M | +58% |
| Q1 2025 | -$164.5M | -$93.1M |
| Q4 2024 | $169.9M | -16% |
| Q3 2024 | $150.5M | -43% |
GIL has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has the edge over GIL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
GIL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +18K shares |
| 1 year | +23% | +34.4M shares |
| 3 years | +4.1% | +7.3M shares |
| 5 years | -7% | -13.9M shares |
| Available history | -8.9% | -18M shares |
GIL has 185M diluted shares, up 23% from a year ago, despite $109M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q2 2026 | $4.8M |
| Q1 2026 | $71.5M |
| Q4 2025 | $3.4M |
| Q3 2025 | $29.4M |
| Q2 2025 | $77.1M |
| Q1 2025 | $87.4M |
| Q4 2024 | $220.6M |
| Q3 2024 | $381.2M |
GIL spent $109M buying back its own shares over the past year, down 86% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over GIL on leverage, with a lower net debt burden relative to earnings.
GIL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 6.4x | High |
| Q1 2026 | 7.5x | High |
| Q4 2025 | 6.1x | High |
| Q3 2025 | 2.2x | Moderate |
| Q3 2024 | 2.1x | Moderate |
| Q2 2024 | 1.8x | Healthy |
| Q1 2024 | 1.6x | Healthy |
| Q4 2023 | 1.4x | Healthy |
GIL's net debt is about 6.4 years of its operating earnings (EBITDA), up from 2.1 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
GIL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 26.2 | Oversold |
| Stochastic | 9.3 | Oversold |
GIL's weekly RSI is 26 (oversold) and its Stochastic is 9 (oversold).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over GIL on valuation relative to its sector.
GIL PE vs Consumer Cyclical Sector
| Metric | GIL | Sector median | Relative |
|---|---|---|---|
| PE | 65x | 18x | 258% above |
| PE % | 96 | 47 | 49 pts above |
GIL is trading at 65x earnings, a 258% premium to the Consumer Cyclical sector's median of 18x.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over GIL on trend strength, trading above more of its moving averages.
GIL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $39.3 | 11% below |
| 20 week MA | $47.5 | 27% below |
| 50 week MA | $55.7 | 37% below |
| 100 week MA | $53.4 | 35% below |
| 200 week MA | $44.5 | 22% below |
GIL is in a downtrend: it's below all five of its weekly moving averages, and 22% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over GIL on returns for 2026, with the stronger performance.
GIL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.6 | $28.2 | -4.5% |
| 2021 | $28.2 | $40.8 | +44% |
| 2022 | $40.8 | $27.1 | -34% |
| 2023 | $27.1 | $33.1 | +22% |
| 2024 | $33.1 | $46.9 | +42% |
| 2025 | $46.9 | $63.6 | +36% |
| 2026 YTD | $63.6 | $34.8 | -45% |
GIL is down 45% so far in 2026, after finishing higher in four of the previous six years.